Cough, Cold and Allergy (Hay Fever) Remedies in Kenya
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN KENYA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Government Aims To Educate and Warn Consumers Against Self-medication
Generic Variants To Gain in Popularity
Counterfeit Drugs Remain A Challenge
Competitive Landscape
Ppb Restricts the Sale of Medicines Containing Codeine
GlaxoSmithKline Maintains Leadership
Decongestant Rubs To Record Stable Growth
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Witnesses Stable Growth in 2018
Potential Taxes on Parallel Imports Expected To Boost Local Manufacturing
Consumers Educated on Identifying Legitimate Pharmacies Through Sms
Technology To Be A Major Disruptor in the Supply Chain
Value Growth Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
The Pharmacy and Poisons Board (PPB) is mandated to promote and protect public health by ensuring that medicines, medical devices and other health technologies are safe, efficacious and of acceptable quality. To this effect, the government has been carrying out awareness campaigns against self-medication. The PPB is ensuring that Kenyans are aware that taking medicine without a health worker’s advice may be very dangerous even for a minor ailment. More importantly, the improper use of drugs has...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Kenya report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.